DANVILLE, Pa. – Geisinger and Merck have collaborated to launch two digital health solutions. The Family Caregiver application helps two-way communications and coordination of care for patients and their caregivers. The MedTrue application integrates different medication data sources to assist with medication reconciliation and adherence, resulting in a patient- and health care team-verified medication list.
The applications are embedded directly within the electronic medical record and in the health care provider’s workflow, and are accessible to patients, and in the case of the Family Caregiver application, to caregivers. Both solutions can be used from the home.
“Our collaboration with Merck has allowed both of our organizations to leverage our individual strengths, expertise and resources to better enable a shared decision-making process through health care technology,” said David Ledbetter, executive vice president and chief scientific officer at Geisinger, in a statement. “Providing these tools for patients and family caregivers—tested within our own system—enables patients to be more active in health care decisions and could increase the likelihood that patients will adhere to their treatment plans and lead healthier lives.”
The applications will use SMART on FHIR (Substitutable Medical Applications, Reusable Technologies / Fast Healthcare Interoperability Resources) technology, an open, standards-based platform for utilizing data from disparate EMRs, so both products can be used in health care systems anywhere.
“Our experience in collaborating with Geisinger, a progressive, integrated delivery system, has given us many insights on the development and testing of solutions to improve patient care and we are confident these applications can be successful with other health systems,” said Lisa French, associate vice president of strategy and commercial model innovation, U.S. market, Merck, in a statement. “We are excited to begin the next phase of our work together, as we actively explore the expanded use and commercialization of these applications with other stakeholders in the health care system.”